Related Experiment Video
Updated: Jun 20, 2025
04:04
Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
381
Acupuncture influences multiple diseases by regulating gut microbiota.
Huimin Xu1,2, Yingzhe Luo3, Qiaoqi Li1
1Department of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Frontiers in Cellular and Infection Microbiology
|July 23, 2024
Summary
Acupuncture, a traditional Chinese medicine therapy, influences gut microbiota composition and function. This review explores acupuncture
Area of Science:
- Integrative Medicine and Microbiology
- Traditional Chinese Medicine Research
Background:
- Acupuncture is a widely used, green, and side-effect-free therapy originating from traditional Chinese medicine.
- Emerging evidence suggests interactions between acupuncture and the gut microbiota.
- These interactions may impact various health conditions.
Purpose of the Study:
- To conduct a thorough analysis of the interactions between acupuncture and gut microbiota.
- To examine the impact of these interactions on various diseases.
- To establish a basis for future clinical applications of acupuncture.
Main Methods:
- Literature review of studies investigating acupuncture and gut microbiota.
- Analysis of alterations in gut microbiota composition and function post-acupuncture.
- Examination of potential clinical outcomes associated with these changes.
Main Results:
- Acupuncture influences the gut microbiota.
- These alterations are linked to potential therapeutic effects in metabolic, gastrointestinal, mental, and nervous system diseases.
- Specific microbial changes correlate with clinical improvements.
Conclusions:
- Acupuncture modulates the gut microbiota, offering potential therapeutic benefits for diverse diseases.
- Understanding these mechanisms can guide the clinical use of acupuncture.
- Further research is warranted to fully elucidate the clinical potential.
Related Concept Videos
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
481
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
481
01:17Irritable Bowel Syndrome I: Introduction
264
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
264
01:17Drugs for Treatment of Diarrhea-Predominant IBS
156
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156